Lanthanum(III) carbonate hydrate

99%

Reagent Code: #202100
label
Alias Lanthanum(III) Carbonate Hydrate
fingerprint
CAS Number 54451-24-0

science Other reagents with same CAS 54451-24-0

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 457.84(anhydrous basis) g/mol
Formula La₂C₃O₉·xH₂O
badge Registry Numbers
EC Number 209-599-5
MDL Number MFCD00149757
inventory_2 Storage & Handling
Storage Room temperature, dry

description Product Description

Used in medicine as a phosphate binder for patients with chronic kidney disease. It helps reduce phosphate levels in the blood by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption. This action supports the management of hyperphosphatemia, a common complication in dialysis patients. The compound releases lanthanum ions in the gut, which form insoluble complexes with phosphate that are excreted in feces. It is taken orally, usually with meals, and is valued for its effectiveness and relatively low risk of aluminum-like toxicity.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 25g
10-20 days ฿350.00
inventory 100g
10-20 days ฿920.00
inventory 500g
10-20 days ฿3,250.00
inventory 2.5kg
10-20 days ฿11,350.00
Lanthanum(III) carbonate hydrate
No image available

Used in medicine as a phosphate binder for patients with chronic kidney disease. It helps reduce phosphate levels in the blood by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption. This action supports the management of hyperphosphatemia, a common complication in dialysis patients. The compound releases lanthanum ions in the gut, which form insoluble complexes with phosphate that are excreted in feces. It is taken orally, usually with meals, and is valued for its effec

Used in medicine as a phosphate binder for patients with chronic kidney disease. It helps reduce phosphate levels in the blood by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption. This action supports the management of hyperphosphatemia, a common complication in dialysis patients. The compound releases lanthanum ions in the gut, which form insoluble complexes with phosphate that are excreted in feces. It is taken orally, usually with meals, and is valued for its effectiveness and relatively low risk of aluminum-like toxicity.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...